Core Viewpoint - U.S. Physical Therapy (USPH) reported quarterly earnings of $0.66 per share, missing the Zacks Consensus Estimate of $0.67 per share, and showing a decline from $0.69 per share a year ago, indicating an earnings surprise of -1.49% [1] Financial Performance - The company posted revenues of $197.13 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.36%, and showing an increase from $168.03 million year-over-year [2] - Over the last four quarters, U.S. Physical Therapy has exceeded consensus revenue estimates four times [2] Stock Performance - U.S. Physical Therapy shares have declined approximately 1.9% since the beginning of the year, contrasting with the S&P 500's gain of 15.1% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.69 on revenues of $198.26 million, and for the current fiscal year, it is $2.61 on revenues of $773.83 million [7] - The estimate revisions trend for U.S. Physical Therapy was mixed ahead of the earnings release, which may change following the recent report [6] Industry Context - The Medical - Outpatient and Home Healthcare industry, to which U.S. Physical Therapy belongs, is currently ranked in the top 18% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

分组1 - ARKO Corp. reported quarterly earnings of $0.1 per share, missing the Zacks Consensus Estimate of $0.12 per share, but showing an increase from $0.07 per share a year ago, resulting in an earnings surprise of -16.67% [1] - The company posted revenues of $2.02 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.97%, but down from $2.28 billion year-over-year [2] - Over the last four quarters, ARKO has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] 分组2 - ARKO shares have declined approximately 32.9% since the beginning of the year, contrasting with the S&P 500's gain of 15.1% [3] - The current consensus EPS estimate for the upcoming quarter is $0.01 on revenues of $1.84 billion, and for the current fiscal year, it is $0.17 on revenues of $7.65 billion [7] - The Zacks Industry Rank for Consumer Products - Staples is currently in the bottom 18% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

Company Performance - Veeco Instruments reported quarterly earnings of $0.36 per share, exceeding the Zacks Consensus Estimate of $0.28 per share, but down from $0.46 per share a year ago, representing an earnings surprise of +28.57% [1] - The company posted revenues of $165.88 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 3.68%, but down from $184.81 million year-over-year [2] - Over the last four quarters, Veeco has consistently surpassed consensus EPS and revenue estimates [2] Stock Outlook - Veeco shares have increased by approximately 8.4% since the beginning of the year, compared to the S&P 500's gain of 15.1% [3] - The company's earnings outlook will be crucial for future stock performance, with current consensus EPS estimates at $0.27 for the coming quarter and $1.27 for the current fiscal year [7] Industry Context - The Electronics - Manufacturing Machinery industry, to which Veeco belongs, is currently ranked in the bottom 26% of over 250 Zacks industries, indicating potential challenges ahead [8] - The performance of Veeco's stock may be influenced by the overall industry outlook and trends in earnings estimate revisions [5][8]

Group 1: Earnings Performance - Eos Energy Enterprises reported a quarterly loss of $4.91 per share, significantly worse than the Zacks Consensus Estimate of a loss of $0.29, representing an earnings surprise of -1,593.10% [1] - The company posted revenues of $30.51 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 23.35%, compared to revenues of $0.85 million a year ago [2] - Over the last four quarters, the company has not surpassed consensus EPS estimates, indicating ongoing challenges in meeting market expectations [2] Group 2: Stock Performance and Outlook - Eos Energy Enterprises shares have increased by approximately 190.1% since the beginning of the year, outperforming the S&P 500's gain of 15.1% [3] - The company's future stock performance will largely depend on management's commentary during the earnings call and the subsequent revisions of earnings estimates [3][4] - The current consensus EPS estimate for the upcoming quarter is -$0.24 on revenues of $81.71 million, and for the current fiscal year, it is -$1.43 on revenues of $147.2 million [7] Group 3: Industry Context - The Industrial Services industry, to which Eos Energy Enterprises belongs, is currently ranked in the bottom 26% of over 250 Zacks industries, which may negatively impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that the company's stock may underperform in the near future due to unfavorable estimate revisions [5][6]

Core Insights - Seadrill reported a quarterly loss of $0.17 per share, missing the Zacks Consensus Estimate of $0.26, and a significant decline from earnings of $0.49 per share a year ago, resulting in an earnings surprise of -165.38% [1] - The company generated revenues of $363 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 10.33% and showing a year-over-year increase from $354 million [2] - Seadrill shares have declined approximately 20.6% year-to-date, contrasting with the S&P 500's gain of 15.1% [3] Financial Performance - Over the last four quarters, Seadrill has surpassed consensus EPS estimates only once [2] - The current consensus EPS estimate for the upcoming quarter is $0.01 on revenues of $308 million, while for the current fiscal year, it is projected at -$0.63 on revenues of $1.35 billion [7] Industry Outlook - The Oil and Gas - Drilling industry, to which Seadrill belongs, is currently ranked in the bottom 10% of over 250 Zacks industries, indicating a challenging environment [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Seadrill's stock performance [5][6]

Core Insights - Tutor Perini reported quarterly earnings of $1.15 per share, exceeding the Zacks Consensus Estimate of $0.96 per share, and a significant improvement from a loss of $1.92 per share a year ago, resulting in an earnings surprise of +19.79% [1] - The company achieved revenues of $1.42 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.34% and showing growth from $1.08 billion in the same quarter last year [2] - Tutor Perini's stock has increased approximately 171.6% year-to-date, significantly outperforming the S&P 500's gain of 15.1% [3] Earnings Outlook - The future performance of Tutor Perini's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is $0.89 on revenues of $1.28 billion, and for the current fiscal year, it is $3.78 on revenues of $5.24 billion [7] Industry Context - The Building Products - Heavy Construction industry, to which Tutor Perini belongs, is currently ranked in the top 32% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Dycom Industries, another company in the same industry, is expected to report quarterly earnings of $3.15 per share, reflecting a year-over-year increase of +17.5%, with revenues projected at $1.4 billion, up 10.1% from the previous year [9]

Core Insights - Hudson Technologies (HDSN) reported quarterly earnings of $0.27 per share, exceeding the Zacks Consensus Estimate of $0.21 per share, and up from $0.17 per share a year ago, representing an earnings surprise of +28.57% [1] - The company posted revenues of $74.01 million for the quarter ended September 2025, which was 1.32% below the Zacks Consensus Estimate, but an increase from $61.94 million year-over-year [2] - Hudson Tech shares have appreciated approximately 52.2% year-to-date, significantly outperforming the S&P 500's gain of 15.1% [3] Earnings Outlook - The future performance of Hudson Tech's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is -$0.03 on revenues of $39.49 million, while for the current fiscal year, the estimate is $0.47 on revenues of $241.4 million [7] Industry Context - The Industrial Services industry, to which Hudson Tech belongs, is currently ranked in the bottom 26% of over 250 Zacks industries, indicating potential challenges ahead [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Financial Performance - Workiva reported quarterly earnings of $0.55 per share, exceeding the Zacks Consensus Estimate of $0.38 per share, and up from $0.21 per share a year ago, representing an earnings surprise of +44.74% [1] - The company posted revenues of $224.17 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.31%, compared to year-ago revenues of $185.62 million [2] Earnings Outlook - The current consensus EPS estimate for the coming quarter is $0.62 on revenues of $230.99 million, and for the current fiscal year, it is $1.34 on revenues of $871.58 million [7] - The estimate revisions trend for Workiva was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Internet - Software industry, to which Workiva belongs, is currently in the top 34% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Viewpoint - Rayonier reported quarterly earnings of $0.32 per share, exceeding the Zacks Consensus Estimate of $0.23 per share, and showing a significant increase from $0.12 per share a year ago, representing an earnings surprise of +39.13% [1][2] Financial Performance - The company achieved revenues of $177.5 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 8.67%, although this is a decline from year-ago revenues of $195 million [2] - Over the last four quarters, Rayonier has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times as well [2] Stock Performance and Outlook - Rayonier shares have declined approximately 16.5% since the beginning of the year, contrasting with the S&P 500's gain of 15.1% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] Estimate Revisions and Rankings - Prior to the earnings release, the estimate revisions trend for Rayonier was unfavorable, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] - The current consensus EPS estimate for the upcoming quarter is $0.13 on revenues of $129.67 million, and for the current fiscal year, it is $0.38 on revenues of $482.27 million [7] Industry Context - The Building Products - Wood industry, to which Rayonier belongs, is currently ranked in the bottom 5% of over 250 Zacks industries, suggesting that the industry outlook could significantly impact the stock's performance [8]

Core Viewpoint - Adma Biologics reported quarterly earnings of $0.16 per share, matching the Zacks Consensus Estimate, and showing a year-over-year increase from $0.15 per share [1] Financial Performance - The company posted revenues of $134.22 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 3.17%, and up from $119.84 million a year ago [2] - Over the last four quarters, Adma Biologics has surpassed consensus revenue estimates three times [2] Stock Performance - Adma Biologics shares have declined approximately 14.7% since the beginning of the year, contrasting with the S&P 500's gain of 15.1% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.18 on revenues of $139.8 million, and for the current fiscal year, it is $0.57 on revenues of $506.7 million [7] - The trend of earnings estimate revisions for Adma Biologics was mixed prior to the earnings release, which may influence future stock movements [5][6] Industry Context - The Medical - Biomedical and Genetics industry, to which Adma Biologics belongs, is currently ranked in the top 40% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]